Scientific Communications and Publications Lead @ (February 2025 - September 2025)
Scientific Communications Consultant @ Alexion/Astra Zeneca Rare Medicine (February 2022 - December 2023)
Senior Director, Global Scientific Communications @ (July 2016 - April 2021)
Director of Medical Publications @ (January 2012 - July 2016)
Director of Publication Practices @ (March 2011 - January 2012)
Director Global Scientific Communications @ (November 2004 - February 2011)
Assistant Director Scientific Communciations @ (September 1996 - November 2004)
Associate Professor of Physiology in Medicine @ (September 1986 - September 1996)
Post-Doctoral Research Associate @ (January 1981 - September 1986)
Kenneth Pomerantz Education
Georgetown University
PhD (Physiology)
1977-1981
Adelphi University
Bachelor of Arts - BA (Biology, General)
1970-1974
Kenneth Pomerantz Skills
Social Media
Publication Planning
Oncology
Therapeutic Areas
Biopharmaceuticals
Clinical Research
Publications
Pharmaceutics
Hematology
Urology
Customer Service
Type 2 Diabetes
Microsoft Office
Medical Writing
Pharmaceutical Industry
Management
Medical Affairs
Scientific Communications
Leadership
Biotechnology
Science
Cardiovascular Disease
Cross Functional Team Leadership
Medical Communications
Strategy
Medical Education
Immunology
Drug Development
Development
Clinical Development
Pharmacology
Clinical Trials
Cardiology
Diabetes
Kenneth Pomerantz Summary
Kenneth Pomerantz, based in Port St. Lucie, FL, US, is currently a Partner at phraktion. Kenneth Pomerantz brings experience from previous roles at KBP Scientific Communications Consultants LLC, BridgeBio, Alexion/Astra Zeneca Rare Medicine and Alexion Pharmaceuticals, Inc.. Kenneth Pomerantz holds a 1977 - 1981 PhD in Physiology @ Georgetown University. With a robust skill set that includes Social Media, Publication Planning, Oncology, Therapeutic Areas, Biopharmaceuticals and more. Kenneth Pomerantz has 4 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Kenneth Pomerantz?
Find contact details for 700 million professionals.